Navigation Links
Japan on the rebound: Implications for Midwest

A favorite topic of mine over the years is Japan. In this column, I have covered different aspects of the Japanese pharmaceutical industry and biotech markets (3/10/03, 8/18/03, 3/28/05). I had the good fortune to return to Japan for the Bio-Jan 2006 Conference in September after a three-yea......

Full article >>> >
Mayor Daley's head of transportation accompanied us on this trip to Japan and came away wowed by the Japanese approach to mass transit. Many more people in Japan use mass transit, a combination of an extensive network of easy-to-use subways and trains, including the high-speed bullet trains - the Shinkansen - than in Chicago.

Upon arriving to Osaka for the Bio-Japan Conference, att......

Full article >>> e over-the-counter (OTC) drugs.

This level compares with the U.S. market, which had pharmaceutical sales of $240.3 billion in 2005, represented 44 percent of the total market, and grew three percent. So the U.S. market is about four times as large as the Japanese market, but remember that the U.S. population is about three times that of Japan (the Japanese population, at about 127 million......

Full article >>> but bi-annual price reductions of eight to 12 percent (although there is talk of reducing prices on an annual basis.) This is another factor driving Japanese companies to merge for greater critical mass (particularly in R&D) and expand their presence in the United States.

The Japanese pharma industry has been slow to embrace the successful pathway used by its automotive counterparts. Neve......

Full article >>> d>Shionogi & Co. (Osaka)$1.7<1%>$0.2+20%49Dainippon Sumitomo Pharma Co. ** (Osaka)New Jersey$1.6+30%$0.1122%Source: MedAd News, Sept. 2006
*now owned by Hoffman LaRoche
**represents merger during last 2 years

Note: sales number vary slig......

Full article >>> >$1.4+23%15.2%17Daiichi Sankyo$1.4+9%20.9%20Astellas Pharma$1.2+11%16.2%23Eisai$0.8+19%16.0%34Chugai$0.4+4%11.8%37Mitsubishi Pharma
Full article >>> ties have gotten on the biotech bandwagon. University professors now are allowed to spend time with start-up companies and share in revenue from out-licensed technologies.

What struck me at the Bio-Japan meeting was the lack of Japanese "Big Pharma" presence at the meeting (very few were there). They seem to be missing out on the growth of their own home-grown market as a source of innova......

Full article >>> lly, the Japanese External Trade Office has a large regional presence in the Midwest with its Chicago office. JETRO played a major role at the Bio-Japan event, fostering partnering sessions and receptions.

I think the time is right for Illinois and the Midwest to build further ties to both the Japanese biotech industry and the second and third tier Japan......

Full article >>> hnology Network, LLC. (WTN). WTN, LLC, accepts no legal liability or responsibility for any claims made or opinions expressed herein.......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 10/23/06


Related biology technology :

1. Japanese delegates highlight Wisconsin at BIO Chicago
2. Japanese telecom opens liason office at UW-Platteville
3. Promega, Japanese lab announce partnership
4. Japanese institute installs Imago system
5. Wisconsin biotechs plan Japan trade mission
6. Sonic Foundry makes Japanese version of lead product
7. OpGen forges agreement with Japanese importer
8. Japanese biotech is booming and linked with Midwest
9. Japans pharma mergers will trickle to the Midwest
10. Japanese institute will develop for UWs Croquet platform
11. Doyles Japan trip opens doors and minds for Wisconsin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences ... the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and ... presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach ...
(Date:10/9/2017)... ... October 09, 2017 , ... The ... medical marijuana products targeting the needs of consumers who are incorporating medical marijuana ... place in Phoenix, Arizona. , As operators of two successful Valley dispensaries, The ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market ... Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast ... from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... , April 11, 2017 No ... but researchers at the New York University Tandon ... of Engineering have found that partial similarities between ... systems used in mobile phones and other electronic ... The vulnerability lies in the fact ...
(Date:4/5/2017)... Allen Institute for Cell Science today announces the launch ... dynamic digital window into the human cell. The website ... deep learning to create predictive models of cell organization, ... suite of powerful tools. The Allen Cell Explorer will ... resources created and shared by the Allen Institute for ...
Breaking Biology News(10 mins):